EI
ARMP icon

EAM Investors’s Armata Pharmaceuticals ARMP Stock Holding History

EAM Investors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$624K Buy
+60,955
New +$513K 0.07% 245

Other funds holding ARMP

MAM
Madison Asset Management Madison, Wisconsin $8.06B AUM 11.81% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM Investors's ARMP Position: Q1 2026 in Review

EAM Investors opened a new position in Armata Pharmaceuticals (ARMP) in Q1 2026: 60,955 shares worth $624K. The stake represents 0.07% of the portfolio and ranks #245 among its holdings.

45 funds tracked by Wall St. Rank hold ARMP as of Q1 2026.

  • EAM Investors held 60,955 shares of Armata Pharmaceuticals worth $624K as of Q1 2026.
  • Armata Pharmaceuticals was a new EAM Investors position in Q1 2026.
  • Armata Pharmaceuticals made up 0.07% of EAM Investors's portfolio in Q1 2026, its #245 holding.
  • 45 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.